DAN SPIRA
CEO
Dan Spira was a former Vice President at Valeant Pharmaceuticals from 2011 to 2015 including Managing Director of iNova Pharmaceuticals and Bausch + Lomb. He was MD of iNova when it was originally sold to Valeant and has now returned as its CEO. The prior 15 years were spent at Johnson & Johnson in various local, regional and global roles as VP, GM and Chief Marketing Officer.